Hormone replacement therapy (HRT) is a medical treatment that helps balance hormone levels in postmenopausal women and assists in relieving menopause symptoms. HRT provides synthetic hormones to supplement or replace hormones that are no longer produced by the body after menopause. Common types of HRT include estrogen-only therapy and estrogen-progestin therapy. Estrogen-only therapy is prescribed for women who have had a hysterectomy. Estrogen-progestin therapy is prescribed for women who still have a uterus to prevent potential risks of endometrial cancer. HRT is primarily used to treat conditions related to declining estrogen levels during and after menopause including hot flashes, night sweats, vaginal dryness, mood swings, sleep issues, and loss of libido. Growing awareness about menopause symptoms and availability of effective treatment options are contributing to the growth of the HRT market.
The global Hormone Replacement Therapy Market is estimated to be valued at US$ 9.6 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.
Growing Awareness About Menopause Symptoms
Increasing awareness regarding menopause symptoms and available treatment options is a key driver boosting adoption of hormone replacement therapy globally. According to the North American Menopause Society, millions of women suffer from moderate to severe menopause symptoms every year owing to declining hormone levels. However, many remain untreated. Marketing and educational campaigns by pharmaceutical companies has increased visibility about menopausal care via social media, digital platforms, and doctors/clinics which is prompting more women to opt for HRT. This growing awareness is expected to fuel demand.
Preference for Non-Invasive Treatment
Women are increasingly seeking effective but non-invasive treatment options to ease menopause symptoms. Hormone replacement therapy provides relief from discomforts through oral tablets, skin patches or gels which are easy-to-use and less complex than other invasive surgical procedures. This non-invasive nature and convenience of HRT administration drives its preference over other therapy types among patients. Introduction of advanced drug delivery modes is further aiding the market growth.
The global hormone replacement therapy market is dominated by two segments- estrogen hormone replacement therapy and human growth hormone replacement therapy. Estrogen hormone replacement therapy accounts for over 60% of the total market share as it is widely used for the treatment of menopause symptoms among women such as hot flashes, night sweats, and vaginal dryness. The therapy helps in alleviating these symptoms by replenishing the estrogen levels in women who have gone through menopause.
Political: Hormone replacement therapy is regulated by various authorities including the Food and Drug Administration in the US and European Medicines Agency in Europe. Any changes made to the existing regulations can impact the sales and usage of HRT products.
Economic: Developed regions like North America and Europe contribute majorly to the global HRT market owing to high awareness levels and developed healthcare infrastructure. However, growing markets such as Asia Pacific are expected to witness faster growth due to improving economic conditions.
Social: With increasing awareness about menopause symptoms and their management, more women are opting for HRT. However, the social stigma associated with aging prevents some from adopting these therapies. Favorable guidelines by governmental and health bodies help address such concerns.
Technological: Ongoing R&D is focused on developing improved drug delivery systems such as transdermal patches and gels to enhance efficacy and safety. Combined hormone therapies are also being researched to widen treatment options.
The global Hormone Replacement Therapy MARKET Trends is expected to witness high growth over the forecast period driven by rising healthcare expenditures in developing nations and the growing aging population globally.
The Asia Pacific region is projected to register the fastest growth in the global HRT market during the forecast period. This can be attributed to the large geriatric population, increased health awareness, and improving access to modern medical technologies in the region. China and India, in particular, are estimated to drive the momentum owing to the presence of nearly 40% of the world’s above 60-year-old population living across the two countries.
Key players operating in the hormone replacement therapy market are Pfizer, Abbott Laboratories, Mylan Laboratories, Novartis, Novo Nordisk, Merck & Co., Eli Lilly and Company, and F. Hoffmann-La Roche. Roche recently received FDA approval for combining estrogen and progesterone in a single drug for the treatment of moderate to severe symptoms of menopause in women with a uterus.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it